The impact of sequential therapy from short-term teriparatide to denosumab compared with denosumab alone in patients with osteoporotic hip fracture: a 1-year follow-up study

Table 1 Demographic findings of this study

Variables	Group 1 (TPTD+DMAb)	Group 2 (DMAb)	p-value
Number	22	16
Age (years)
Mean ± SD	75.9 ± 6.06	75.4 ± 7.94	0.831
Diagnosis (N)
ITN/FN/STN	17/4/1	7/9/0	0.06
PTH (ng/ml)
Mean ± SD	43.44 ± 22.05	42.94 ± 20.38	0.951
Vit D (ng/ml)
Mean ± SD	19.37 ± 15.20	8.23 ± 4.04	0.025
Initial Hip BMD (g/cm³)
Mean ± SD	0.650 ± 0.11	0.626 ± 0.11	0.506
Initial Spine BMD (g/cm³)
Mean ± SD	0.735 ± 0.14	0.702 ± 0.11	0.420

ITN intertrochanter fracture, FN femur neck fracture, STN subtrochanter fracture, PTH parathyroid hormone, BMD bone mineral density

ISSN: 1471-2474